Overcoming Therapeutic Inertia in Type 2 Diabetes: Benefiting Patients, Clinicians, and Health Systems

Overcoming Therapeutic Inertia in Type 2 Diabetes: Benefiting Patients, Clinicians, and Health Systems | Recorded Webinar

Description

This American Diabetes Association® webinar is designed for health care administrators, health care executives, payors, and change leaders in the health care industry. As stakeholders tackling the problem of therapeutic inertia in the care of individuals with type 2 diabetes, your support and collaborative efforts with patients and health professionals will yield demonstrated health outcomes and efficiencies. Webinar participants will acquire valuable insights as to how to actively contribute to improving health industry goals in people with diabetes.

Speakers

Christine Beebe, MS, RD, CDCES, LD
QuantuMed Consulting

Nay Linn Aung, MD, D-ACD, BC-ADM
Mohawk Valley Health System

Moderator

Robert Gabbay, MD, PhD
American Diabetes Association

Learning Objectives

Identify the impact of therapeutic inertia on diabetes outcomes
Recognize factors that contribute to therapeutic inertia in people with type 2 diabetes
Discover effective strategies and best practices to reduce therapeutic inertia

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account